Question 1

What is Teneobio?

Accepted Answer

Teneobio is a Entity.

Question 2

How often does Teneobio appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Teneobio first tracked by Ergen?

Accepted Answer

First tracked on Jun 15, 2026.

Question 4

When was Teneobio last mentioned in news?

Accepted Answer

Last active on Jun 15, 2026.

Question 5

What is Teneobio's current news sentiment?

Accepted Answer

Aggregate sentiment score: -50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Teneobio in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Teneobio?

Accepted Answer

Harbour BioMed Wins Amgen Patent Suit (Jun 15, 2026, 6 articles).

Question 8

How did the "Harbour BioMed Wins Amgen Patent Suit" event impact Teneobio?

Accepted Answer

Teneobio, an Amgen subsidiary, was found to have infringed Harbour BioMed's patent, contributing to the damages awarded against Amgen. This event reflects negatively on Teneobio's intellectual property practices.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.